Kongreß pp 481-493 | Cite as

Proteinurie bei Systemerkrankungen

  • J. E. Scherberich
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 93)

Zusammenfassung

Klassische Systemerkrankungen wie Diabetes mellitus, Lupus erythematodes, aber auch arterielle Hypertonie, Gicht, pararheumatische Erkrankungen, Neoplasien und Infektionen gehen typischerweise in unterschiedlicher Frequenz mit einer Nierenbeteiligung einher [18,40,61]. Damit verschlechtert sich die Prognose der Grunderkrankung z.T. erheblich [18, 25, 40, 61, 69].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ala-Houhala I, Pasternak A (1987) Fractional dextran and protein clearances in glomerulonephritis and in diabetic nephropathy. Clin Sci 72: 289–296PubMedGoogle Scholar
  2. 2.
    Alavi N, Lianos EA, Venuto RC, et al. (1986) Reduction of proteinuria by indomethacin in patients with nephrotic Syndrome. Am J Kidney Dis 8: 397–403PubMedGoogle Scholar
  3. 3.
    Allegri L, Olivetti G, David S, et al. (1980) Sarcoid granulomatous nephritis with isolated and reversible renal failure. Nephron 25: 207–208PubMedCrossRefGoogle Scholar
  4. 4.
    Alpers CE, Cotran RS (1986) Neoplasia and glomerular injury: Kidney Int 30: 465–473PubMedGoogle Scholar
  5. 5.
    Baba T, Ishizaki T, Ido Y, et al. (1987) Renal effects of Nicardipine, a Ca++ entry blocker, in hypertensive type II diabetic patients with nephropathy. Diabetes 35: 1206–1214CrossRefGoogle Scholar
  6. 6.
    Balow JE, et al. (1984) Effect of treatment on the evolution of renal abnormalities in Lupus nephritis. N Engl J Med 311: 491–495PubMedCrossRefGoogle Scholar
  7. 7.
    Bank N, Klose R, Aynedjian HS, et al. (1987) Evidence against increased glomerular pressure initiating diabetic nephropathy. Kidney Ing 31: 898–905CrossRefGoogle Scholar
  8. 8.
    Batuman V, Sastrasinh M, Saastrasinh S (1986) Light chain effects on alanine and glucose uptake by renal brush border membranes. Kidney Int 30: 662–665PubMedCrossRefGoogle Scholar
  9. 9.
    Bent-Hansen L, Feldt-Rasmussen B, Kverneland A, Deckert T (1987) Transcapillary escape rate and relative metabolic clearance of glycated and non-glycated albumin in type I (insulin-dependent) diabetes mellitus. Diabetologia 30: 2–4PubMedCrossRefGoogle Scholar
  10. 10.
    Birk HW, Scherberich JE, Schoeppe W (1986) Radioimmunoblotting of tubule derived glycoproteins in urine from patients with kidney diseases. Nieren- u. Hochdruckkrankheiten 15: 385 (abstract)Google Scholar
  11. 11.
    Boesken WH (1976) Molekulargewichtsbezogene Analysen der Proteinurie als Beitrag zur Diagnose renaler Erkrankungen. Med Klin 71: 441–448PubMedGoogle Scholar
  12. 12.
    Boesken WH, Kopf K, Schollmeyer P (1973) Differentiation of Proteinurie diseases by discelectrophoretic molecular weight analysis of urinary proteins. Clin Nephrol 5: 311–318Google Scholar
  13. 13.
    Boesken WH, Rohrbach R, Schollmeyer P (1978) Vergleich von Histologie und Urinproteinanalyse bei Nierenerkrankungen. Nieren- und Hochdruckkrankheiten 5: 206–214Google Scholar
  14. 14.
    Boesken W, Schott S, Raif W, et al. (1982) Die Leichtketten- Tubulopathie (Bence-Jones-Nephropathie): Biochemische, morphologische und klinische Befunde. In: Schlegel B (Hrsg) Verhandlungen der Deutschen Gesellschaft für Innere Medizin, 88. Band. Bergmann, München, pp 919–922Google Scholar
  15. 15.
    Boulton-Jones JM, et al. (1986) Variation in charge on red cells of patients with different glomerulopathies. Lancet II: 186–188CrossRefGoogle Scholar
  16. 16.
    Boyce NW, Holdsworth SR (1986) Direct antiGBM antibody induced alterations in glomerular permselectivity. Kidney Int 30: 666–672PubMedCrossRefGoogle Scholar
  17. 17.
    Brandhorst D, Wetter O (1980) Study of uroproteins in myeloma patients by SDS-PAGE. Klin Wochenschr 58: 585–587PubMedCrossRefGoogle Scholar
  18. 18.
    Brenner BM, Rector FC (eds) (1986) The Kidney, 3rd edn. Saunders, Philadelphia London TorontoGoogle Scholar
  19. 19.
    Chander P, Soni A, Suri A, et al. (1987) Renal ultrastructural markers in AIDS-associated nephropathy. Am J Pathol 126: 513–526PubMedGoogle Scholar
  20. 20.
    Cohen AS, Connors LH (1987) The pathogenesis and biochemistry of amyloidosis. J Pathol 151: 1–10PubMedCrossRefGoogle Scholar
  21. 21.
    Cummings N, Michael AF, Wilson CB (eds) Immune mechanisms in renal disease. Plenum, New York LondonGoogle Scholar
  22. 22.
    Donadio JV (1984) Cytotoxic-drug treatment of lupus nephretis. N Engl J Med 311: 528–529PubMedCrossRefGoogle Scholar
  23. 23.
    Ehrich JHH (1977) Pathogenese der Malaria- Nephropathien. In: Dietrich M, Schönfeld H (eds) Malaria (Diagnose-Klinik-Therapie). Roche, pp 53–73Google Scholar
  24. 24.
    Evans DJ, Cashman SJ, Walport M (1987) Progressive systemic sclerosis: autoimmune arteriopathy. Lancet 1: 480–482PubMedCrossRefGoogle Scholar
  25. 25.
    Fang LST (1985) Light-chain nephropathy. Kidne Int 27: 582–592CrossRefGoogle Scholar
  26. 26.
    Ganeval D, Cathomen M, Noel L-H, Grünfeld JP (1982) Kidney involvement in multiple myeloma and related disorders. Contrib Nephrol 33: 210–222PubMedGoogle Scholar
  27. 27.
    Gassmann W, Haferlach T, Schmitz N, et al. (1984) Analyse prognostischer Faktoren beim Plasmozytom. Klin Wochenschr 62: 896–905PubMedCrossRefGoogle Scholar
  28. 28.
    Gläser V, Lang RF, et al. (1981) Nierenbeteiligung bei „Mixed connective tissue disease“(Sharp-Syndrom). Z Urol Nephrol 74: 501–508PubMedGoogle Scholar
  29. 29.
    Grabensee B, Kutkuhn B, Geering P (1987) Klinik und Verlauf der Amyloidose mit Nierenbeteiligung. Nieren- u. Hochdruckkrankheiten 16: 153–160Google Scholar
  30. 30.
    Gross WL (1987) Wegenersche Granulomatose: Immunologische Aspekte zur Diagnostik, Genese und Therapie. Immun Infekt 15: 15–25PubMedGoogle Scholar
  31. 31.
    Guder W, Heidland A (eds) (1986) Kleinkonferenz „Harnanalytik“. Nieren- u. Hochdruckkrankheiten 15, 5: 205Google Scholar
  32. 32.
    Guder W, Dubach U (eds) (1979) Enzymes and proteins in pathological urine. Current Problems in Clinical Biochemistry, Vol. 9. Huber, BernGoogle Scholar
  33. 33.
    Heiin H, Korpela M, Mustonen J, Pasternak A (1986) Mild mesangial glomerulopathia - a frequent finding in rheumatoid arthritis patients with hematuria and proteinuria. Nephron 42: 224–230CrossRefGoogle Scholar
  34. 34.
    Hommel E, Mathiesen E, Arnold-Larsen S, et al. (1987) Effects of indomethacin on kidney function in type I (insulin-dependent) diabetic patients with nephropathy. Diabetologia 30: 78–81PubMedGoogle Scholar
  35. 35.
    Hommel E, et al. (1986) Effect of Captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293: 467–470CrossRefGoogle Scholar
  36. 36.
    Hory B, et al. (1987) Waldenström macroglobilinemia and nephrotic Syndrome with minimal change lesions. Nephron 45: 68–70PubMedCrossRefGoogle Scholar
  37. 37.
    Jungmann E, Mondorf W, Scherberich JE, Sperzel R, Schöffling W (1982) Über die Schädigung des tubulären Apparats der Niere bei pathologischer Glucosetoleranz. MMW 124: 231–233Google Scholar
  38. 38.
    Kyle RA, Greipp PR (1982) „Idiopathic“Bence Jones Proteinura. N Engl J Med 306: 564–567Google Scholar
  39. 39.
    Lee HS, Mujais SK, Kasinath BS, et al. (1984) Course of renal pathology in patients with systemic lupus erythematosus. Am J Med 77: 612–620PubMedCrossRefGoogle Scholar
  40. 40.
    Massry SG (ed) (1977) Kidney in systemic disease. Contributions in Nephrology, Vol. 7. Karger, BaselGoogle Scholar
  41. 41.
    MensingH (1987) Leukozytoklastische Vaskulitis. Immun Infekt 15: 9–14Google Scholar
  42. 42.
    Meyrier A, Simon P, Mignon F, et al. (1984) Rapidly progressive (‚crescentic’) glomerulonephritis and monoclonal gammopathies. Nephron 38: 156–162PubMedCrossRefGoogle Scholar
  43. 43.
    Mogensen CE (1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31: 673–689PubMedCrossRefGoogle Scholar
  44. 44.
    Mondorf W, Scherberich JE (1986) Bildatlas der normalen Niere. Vieweg, Braunschweig WiesbadenGoogle Scholar
  45. 45.
    O’Dell JR, Hays RC, Guggenheim SJ, et al. (1985) Tubulointerstitial renal disease in systemic lupus erythematosus. Arch (Intern) Med 145: 1996–1999CrossRefGoogle Scholar
  46. Österby R (1986) Structural changes in the diabetic kidney. Clinics in Endocrinology and Metabolism, Vol. 15. Saunders, London, pp 773–751Google Scholar
  47. 47.
    Park MH, Agati VD, Appel GB, Pirani CL (1986)Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44: 309–319Google Scholar
  48. 48.
    Pesce AJ, First MR (1979) Proteinuria, an integrated review. Marcel Dekker, New York BaselGoogle Scholar
  49. 49.
    Peter HH (1987) Einteilung und Pathogenese der Vaskulitiden. Immun Infekt 15: 3–8PubMedGoogle Scholar
  50. 50.
    Rao DS, et al. (1987) Hypophosphatemic osteomalacia and adult Fanconi Syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia. Am J Med 82: 333–338PubMedCrossRefGoogle Scholar
  51. 51.
    Rao TK, Friedman EA, Nicastri AD (1987) The types of renal disease in the acquired immunodeficiency Syndrome. N Engl J Med 316: 1062–1068PubMedCrossRefGoogle Scholar
  52. 52.
    Scherberich JE (1986) Proteinverteilungsmuster im Harn: wertvolle Hilfe bei der Diagnostik glomerulärer und tubulärer Erkrankungen. Bioscientia Bericht No. 28, Nov. 1986Google Scholar
  53. 53.
    Scherberich JE, Mondorf W, Falkenberg FW, Pierard D, Schoeppe W (1985) Monitoring tubulär damage under clinical conditions: use of poly- and monoclonal anti-kidney antibodies as a tool. In: Lubec G, Campese V (eds) Advances in Noninvasive Nephrology. Libbey, London, pp 278–285Google Scholar
  54. 54.
    Scherberich JE, Sniehotta KP, Miehlke K, Schoeppe W (1987) Nierenbeteiligung bei rheumatoider Arthritis. Nieren- u. Hochdruckkrankheiten 16: 69–77Google Scholar
  55. 55.
    Scherberich JE, Soler G, Schoeppe W (1985) Non- invasive diagnosis of kidney diseases applying sensitive thin-layer SDS-PAA gradient gel electrophoresis. Prot Biol Fluids 33: 533–536Google Scholar
  56. 56.
    Scherberich JE, Wehrheim M, Weidmann HG, et al. (1985) Disturbance in renal handling of proteins in patients with kidney diseases as evaluated by sensitive inverse radial-immunoassay and SDS-polyacrylamide gel electrophoresis: In: Lubec G, Campese V (eds) Advances in Noninvasive Nephrology. Libbey, London, pp 212–218Google Scholar
  57. 57.
    Schifferdecker E, Scherberich JE, Döring H, et al. (1987) Ausscheidung von Albumin und tubulären Enzymen bei insulinbehandelten Diabetikern—Verlaufsuntersuchungen über ein Jahr. 22. Tag. Dtsch. Diabet. Ges., Aachen 28.–30. 5. 1987 (abstract)Google Scholar
  58. 58.
    Schoeppe W ( 1982 Nephropathien bei Bluterkrankungen und malignen Neoplasien. In: Losse H, Renner E (eds) Klinische Nephrologie, Bd. II. Thieme, Stuttgart, pp 377–389Google Scholar
  59. 59.
    Schoeppe W, Scherberich JE, Hofmann G, Rosak C (1986) Proteinurie und Enzymurie bei Gesunden und Typ-I-Diabetikern unter standardisierten Belastungsbedingungen. Mitt. Dtsch. Ges. f. Klin. Chem. 3: 134–135Google Scholar
  60. 60.
    Schollmeyer P (1982) Erworbene Tubulopathien: In: Losse H, Renner E (eds) Klinische Nephrologie. Thieme, Stuttgart, p 350Google Scholar
  61. 61.
    Schulz W (ed) (1987) Systemerkrankungen und Niere I. Nieren- und Hochdruckkrankheiten 16, 2Google Scholar
  62. 62.
    Singer DRJ, Evans DJ (1986) Renal impairment in sarcoidosis; granulomatous nephritis as an isolated cause. Clin Nephrol 26: 250 - 256PubMedGoogle Scholar
  63. 63.
    Skaarup P, Jensenius JC, Brandslund I (1984) Association of circulating immune complexes with glomerular proteinuria in patients with transitional cell Carcinoma of the urinary bladder. Eur Urol 10: 249–253PubMedGoogle Scholar
  64. 64.
    Smithline N, Kassirer JP, Cohen JJ (1976) Renal tubular dysfunctions associates with light-chain proteinuria. N Engl J Med 294: 71–74PubMedCrossRefGoogle Scholar
  65. 65.
    Smolens P, Barnes JL, Stein JH (1986) Effect of chronic administration of different Bence Jones proteins on rat kidney. Kidney Int 30: 874–882PubMedCrossRefGoogle Scholar
  66. 66.
    Sobh MA, et al. (1987) Schistosomal specific nephropathy leading to end-stage renal failure. Kidney Int 31: 1006–1011PubMedCrossRefGoogle Scholar
  67. 67.
    Stamenkovic I, Favre H, Donath A, et al. (1986) Renal biopsy in SLE irrespective of clinical findings: longterm follow-up. Clin Neprol 26: 109–115Google Scholar
  68. 68.
    Stierle HE, Schott S, Boesken WH (1987) Diagnostik und Verlaufsbeobachtungen bei Bence-Jones Tubulopathie. Nieren- und Hochdruckkrankheiten 16: 116–119Google Scholar
  69. 69.
    Ten Berge IJM, Wilmink JM, Meyer CJLM, et al. (1985) Clinical and immunological follow-up of patients with severe renal disease in Wegener’s granulomatosis. Am J Neuphrol 5: 21–29CrossRefGoogle Scholar
  70. 70.
    Viberti GC, Wiseman MJ (1986) The kidney in diabeties: significance of the early abnormalities. Clin Endocrinol Metab 15: 753–782PubMedCrossRefGoogle Scholar
  71. 71.
    Wardle EN (1987) Diabetic Nephropathy. Nephron 4: 177–181CrossRefGoogle Scholar
  72. 72.
    Yoshioka T, Mitarai T, Kon V, et al. (1986) Role of angiotensin II in an overt functional proteinuria. Kidney Int 30: 538–545PubMedCrossRefGoogle Scholar
  73. 73.
    Yokoyama H, Kida H, Asamato T (1986) Gouty kidney associated with membranous nephropathy: participation of renal tubulär epithelial antigen. Nephron 44: 361–364PubMedCrossRefGoogle Scholar
  74. 74.
    Zankovich R, Lorenz R, Diehl V (1987) Nierenbeteiligung bei malignen Lymphomen. Med Klin 82 (9): 301–305Google Scholar
  75. 75.
    Zemer D, et al. (1986) Colchicine in the prevention and treatment of the amyloidosis of familial mediterranean fever. N Engl J Med 314: 1001–1105sPubMedCrossRefGoogle Scholar

Copyright information

© J. F. Bergmann Verlag, München 1987

Authors and Affiliations

  • J. E. Scherberich
    • 1
  1. 1.Zentrum der Inneren MedizinUniversitätsklinik Frankfurt/MainDeutschland

Personalised recommendations